Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bfbadd0db7ea4150835dece895ab3e166> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bfbadd0db7ea4150835dece895ab3e166 NCIT_P378 "NCI" @default.
- Bfbadd0db7ea4150835dece895ab3e166 type Axiom @default.
- Bfbadd0db7ea4150835dece895ab3e166 annotatedProperty IAO_0000115 @default.
- Bfbadd0db7ea4150835dece895ab3e166 annotatedSource NCIT_C127906 @default.
- Bfbadd0db7ea4150835dece895ab3e166 annotatedTarget "A mixture of two humanized immunoglobulin G1 (IgG1) monoclonal antibodies, Hu9006 and Hu9338, which recognize non-overlapping epitopes in the extracellular domain of the human hepatocyte growth factor receptor (MET; HGFR; c-Met), with potential antineoplastic activity. Upon administration, anti-MET monoclonal antibody mixture Sym015 targets and binds to the extracellular domain of MET, thereby preventing the binding of its ligand, hepatocyte growth factor (HGF). This may prevent activation of the receptor and MET-mediated signal transduction pathways. This inhibits MET-dependent tumor cell proliferation. MET, a receptor tyrosine kinase, is overexpressed on the cell surfaces of various solid tumor cell types; it plays a key role in cancer cell growth, survival, angiogenesis, invasion, and metastasis." @default.